Progenitor Cells
Showing 1 - 25 of >10,000
Heart Failure With Reduced Ejection Fraction Trial (Extracellular vesicle-enriched secretome of cardiovascular progenitor cells
Not yet recruiting
- Heart Failure With Reduced Ejection Fraction
- Extracellular vesicle-enriched secretome of cardiovascular progenitor cells differentiated from induced pluripotent stem cells
- (no location specified)
Mar 7, 2023
(LTFU) of Patients Treated With Genome-edited Autologous
Not yet recruiting
- Sickle Cell Disease
- OTQ923
- (no location specified)
Nov 24, 2023
Knee Osteoarthritis Trial in Shanghai, Beijing, Hangzhou (Mesenchymal progenitor cells, Sodium Hyaluronate Injection)
Not yet recruiting
- Knee Osteoarthritis
- Mesenchymal progenitor cells
- Sodium Hyaluronate Injection
-
Shanghai, Shanghai, China
- +5 more
Aug 9, 2023
Blood Endothelium Progenitor Cells and Dendritic Cells as
Completed
- Atherosclerosis
- Restenosis
-
Edegem, Antwerpen, BelgiumUniversitair Ziekenhuis Antwerpen
Nov 3, 2022
Acute Ischemic Stroke Trial in Beijing (iEPCs, Clinical standard treatment (CST))
Not yet recruiting
- Acute Ischemic Stroke
- iEPCs
- Clinical standard treatment (CST)
-
Beijing, Beijing, ChinaAllife
Aug 14, 2023
Retinitis Pigmentosa Trial in Irvine, Los Angeles, Boston (human retinal progenitor cells)
Completed
- Retinitis Pigmentosa
- human retinal progenitor cells
-
Irvine, California
- +2 more
Aug 8, 2022
Sepsis, Endotoxemia, Immunosuppression Trial in Nijmegen (LPS, Placebo)
Completed
- Sepsis, Endotoxemia, Immunosuppression
- LPS
- Placebo
-
Nijmegen, Gelderland, NetherlandsIntensive Care Medicine, Radboud University Nijmegen Medical Cen
Oct 4, 2022
Age-Related Macular Degeneration Trial (Cultured retinal stem and progenitor cells, Standard treatment according to the clinical
Not yet recruiting
- Age-Related Macular Degeneration
- Cultured retinal stem and progenitor cells
- Standard treatment according to the clinical protocols
- (no location specified)
Dec 24, 2021
Progenitor Cells in Human Esophagus
Active, not recruiting
- Progenitor Cells
- +2 more
-
Rochester, MinnesotaMayo Clinic
Nov 9, 2021
Retinitis Pigmentosa Trial in Irvine, Los Angeles, Boston (human retinal progenitor cells, Mock injection)
Completed
- Retinitis Pigmentosa
- human retinal progenitor cells
- Mock injection
-
Irvine, California
- +2 more
Mar 3, 2022
Adenosine Deaminase Severe Combined Immune Deficiency Trial (A cryopreserved formulation of autologous mPB CD34+ hematopoietic
Not yet recruiting
- Adenosine Deaminase Severe Combined Immune Deficiency
- A cryopreserved formulation of autologous mPB CD34+ hematopoietic stem and progenitor cells transduced ex vivo with the EFS-ADA lentiviral vector encoding the human ADA enzyme
- (no location specified)
Jun 20, 2022
Sickle Cell Disease Trial in Italy, United States (OTQ923, HIX763, OTQ923 or HIX763)
Recruiting
- Sickle Cell Disease
- OTQ923
-
Los Angeles, California
- +4 more
Jan 9, 2023
Aging, Exercise, Cardiovascular Disease Trial in Baltimore (Exercise Training, Exercise Cessation)
Active, not recruiting
- Aging
- +2 more
- Exercise Training
- Exercise Cessation
-
Baltimore, MarylandUniversity of Maryland, Baltimore & Baltimore VA Medical Center
Feb 28, 2022
Endothelial Dysfunction, Diabetes, Type 1, Biomarkers Trial in Celje (Semaglutide Pen Injector [Ozempic], Empagliflozin 10 MG)
Completed
- Endothelial Dysfunction
- +9 more
- Semaglutide Pen Injector [Ozempic]
- Empagliflozin 10 MG
-
Celje, SloveniaGeneral Hospital Celje
May 10, 2023
AIDS-related Non-Hodgkin Lymphoma, AIDS-related Plasmablastic Lymphoma, AIDS-related Primary Effusion Lymphoma Trial in Duarte
Active, not recruiting
- AIDS-related Non-Hodgkin Lymphoma
- +3 more
- busulfan
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma Trial run by the
Active, not recruiting
- AIDS-Related Burkitt Lymphoma
- +5 more
- Prednisone
- +7 more
-
Bethesda, MarylandNCI Lymphoid Malignancies Branch
Jul 31, 2022
Studies of Neuregulin/ERBB Signaling in Human Heart
Recruiting
- Heart Disease
- +2 more
-
Portland, MaineMaine Medical Center
Nov 22, 2022
Multiple Sclerosis Trial in New York (Intrathecal MSC-NP injection, Intrathecal saline injection)
Active, not recruiting
- Multiple Sclerosis
- Intrathecal MSC-NP injection
- Intrathecal saline injection
-
New York, New YorkTisch MS Research Center of New York
Oct 25, 2022
Beta-Thalassemia Trial in Nanning (CS-101)
Recruiting
- Beta-Thalassemia
- CS-101
-
Nanning, ChinaThe First Affiliated Hospital of Guangxi Medical University
Sep 9, 2023
AIDS-related Lymphoma, HIV Trial in Hamburg (PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC))
Terminated
- AIDS-related Lymphoma
- HIV Infections
- PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC)
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Sep 4, 2022
Gingival Recession, Lack of Keratinized Gingiva (Disorder) Trial in Birmingham (progenitor potential of Gingival Mesenchymal
Active, not recruiting
- Gingival Recession
- Lack of Keratinized Gingiva (Disorder)
- progenitor potential of Gingival Mesenchymal cells
-
Birmingham, AlabamaUAB School of Dentistry Department of Periodontology
Jan 5, 2023
Type 2 Diabetes Trial in Baltimore (Aerobic Exercise Training)
Active, not recruiting
- Type 2 Diabetes Mellitus
- Aerobic Exercise Training
-
Baltimore, MarylandBaltimore VA Medical Center
Feb 28, 2022
Hypoplastic Left Heart Syndrome, Single Ventricle, Heart Failure Trial in Okayama (Autologous cardiac progenitor cell
Completed
- Hypoplastic Left Heart Syndrome
- +2 more
- Autologous cardiac progenitor cell transplantation
- staged shunt procedure
-
Okayama, JapanDepartment of Regenerative Medicine, Center for Innovative Clini
Nov 23, 2021